Ventilator-associated pneumonia (VAP) is a severe, frequent and potentially fatal complication in the intensive care unit (ICU). Treatment failure (TF) in VAP is defined as the lack of improvement in clinical parameters and/or the persistence of the infecting microorganism, and is associated with...
Treatment of Nosocomial Pneumonia Patients with severe hospital-acquired pneumonia (HAP) or health care–acquired pneumonia who require mechanical ventilatory support should be treated in a fashion similar to that of patients with ventilator-associated pneumonia (VAP). ...
Ventilator-associated pneumonia is a common complication in intensive care units, occurring in 9% to 24% of patients intubated for longer than 48 hours.
Treatment with antibiotics leads to the selection of isolates with increased resistance. We investigated if evolution towards resistance was associated with virulence changes, in the context of.ventilator-associated pneumonia (VAP). Four patients were selected because they had multiple VAP episodes during...
Shorr and others to a letter to the editor about his article "Levofloxacin for Treatment of Ventilator-Associated Pneumonia: Putting the Cart Before the Horse," which was published in one of the previous issues of the journal "Clinical Infectious Diseases."...
pneumonia (redirected fromVentilator-associated pneumonia) Thesaurus Medical Acronyms Encyclopedia Wikipedia pneu·mo·nia (no͝o-mōn′yə, nyo͝o-) n. An acute or chronic disease marked by inflammation of the lungs, usually caused by a bacterium, virus, or other infectious agent. ...
BackgroundInfections caused by extensive drug-resistant Acinetobacter baumannii (XDR-AB) have been increasingly observed and are associated with a high mortality rate. We present our experience using aerosolized colistin for the treatment of ventilator-associated pneumonia (VAP) due to XDR-AB in neonate...
Levofloxacin for treatment of ventilator-associated pneumonia: A subgroup analysis from a randomized trial. Clin Infect Dis 2005;40(Suppl 2):S123-9... M Pierre,Bédos Jean-Pierre - 《Clinical Infectious Diseases An Official Publication of the Infectious Diseases Society of America》 被引量: 27发...
Ventilator-associated pneumonia (VAP) caused by multidrug-resistant (MDR) Gram-negative bacteria (GNB) has emerged as an important and intractable clinical problem. This review assessed the efficacy and safety of colistin for treatment of MDR GNB VAP. PubMed and Embase were searched for controlled...
The Role of Aerosolized Colistin in the Treatment of Ventilator-Associated Pneumonia: A Systematic Review and Metaanalysis* Objectives: The present meta-analysis and systematic review evaluated the efficacy and safety of aerosolized colistin as adjunctive therapy to IV antimicro... A Valachis,G Samon...